663 related articles for article (PubMed ID: 29687200)
1. Are Probiotics Effective in Targeting Alcoholic Liver Diseases?
Hong M; Han DH; Hong J; Kim DJ; Suk KT
Probiotics Antimicrob Proteins; 2019 Jun; 11(2):335-347. PubMed ID: 29687200
[TBL] [Abstract][Full Text] [Related]
2. Microbiota-based treatments in alcoholic liver disease.
Sung H; Kim SW; Hong M; Suk KT
World J Gastroenterol; 2016 Aug; 22(29):6673-82. PubMed ID: 27547010
[TBL] [Abstract][Full Text] [Related]
3. Alcoholic liver disease: the gut microbiome and liver cross talk.
Hartmann P; Seebauer CT; Schnabl B
Alcohol Clin Exp Res; 2015 May; 39(5):763-75. PubMed ID: 25872593
[TBL] [Abstract][Full Text] [Related]
4. Alcohol or Gut Microbiota: Who Is the Guilty?
Meroni M; Longo M; Dongiovanni P
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540133
[TBL] [Abstract][Full Text] [Related]
5. Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice.
Ferrere G; Wrzosek L; Cailleux F; Turpin W; Puchois V; Spatz M; Ciocan D; Rainteau D; Humbert L; Hugot C; Gaudin F; Noordine ML; Robert V; Berrebi D; Thomas M; Naveau S; Perlemuter G; Cassard AM
J Hepatol; 2017 Apr; 66(4):806-815. PubMed ID: 27890791
[TBL] [Abstract][Full Text] [Related]
6. Targeting the gut microbiota to treat alcoholic liver diseases: evidence and promises.
Leclercq S; de Timary P; Stärkel P
Acta Gastroenterol Belg; 2020; 83(4):616-621. PubMed ID: 33321019
[TBL] [Abstract][Full Text] [Related]
7. Microbiome as a therapeutic target in alcohol-related liver disease.
Sarin SK; Pande A; Schnabl B
J Hepatol; 2019 Feb; 70(2):260-272. PubMed ID: 30658727
[TBL] [Abstract][Full Text] [Related]
8. Compound Probiotic Ameliorates Acute Alcoholic Liver Disease in Mice by Modulating Gut Microbiota and Maintaining Intestinal Barrier.
Liu H; Kang X; Yang X; Yang H; Kuang X; Ren P; Yan H; Shen X; Kang Y; Li L; Wang X; Guo L; Tong M; Fan W
Probiotics Antimicrob Proteins; 2023 Feb; 15(1):185-201. PubMed ID: 36456838
[TBL] [Abstract][Full Text] [Related]
9. Intestinal HIF-1α deletion exacerbates alcoholic liver disease by inducing intestinal dysbiosis and barrier dysfunction.
Shao T; Zhao C; Li F; Gu Z; Liu L; Zhang L; Wang Y; He L; Liu Y; Liu Q; Chen Y; Donde H; Wang R; Jala VR; Barve S; Chen SY; Zhang X; Chen Y; McClain CJ; Feng W
J Hepatol; 2018 Oct; 69(4):886-895. PubMed ID: 29803899
[TBL] [Abstract][Full Text] [Related]
10. Alcohol, liver disease and the gut microbiota.
Bajaj JS
Nat Rev Gastroenterol Hepatol; 2019 Apr; 16(4):235-246. PubMed ID: 30643227
[TBL] [Abstract][Full Text] [Related]
11. Inulin Ameliorates Alcoholic Liver Disease via Suppressing LPS-TLR4-Mψ Axis and Modulating Gut Microbiota in Mice.
Yang X; He F; Zhang Y; Xue J; Li K; Zhang X; Zhu L; Wang Z; Wang H; Yang S
Alcohol Clin Exp Res; 2019 Mar; 43(3):411-424. PubMed ID: 30589437
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiota in alcoholic liver disease: pathogenetic role and therapeutic perspectives.
Malaguarnera G; Giordano M; Nunnari G; Bertino G; Malaguarnera M
World J Gastroenterol; 2014 Nov; 20(44):16639-48. PubMed ID: 25469033
[TBL] [Abstract][Full Text] [Related]
13. Gut dysbiosis correction contributes to the hepatoprotective effects of
Yan X; Wang Y; Ren XY; Liu XY; Ma JM; Song RL; Wang XH; Dong Y; Yu AX; Fan QQ; Wei J; She GM
Food Funct; 2021 Oct; 12(20):10281-10290. PubMed ID: 34549762
[TBL] [Abstract][Full Text] [Related]
14. The intestinal microbiota as a therapeutic target in the treatment of NAFLD and ALD.
Huang W; Kong D
Biomed Pharmacother; 2021 Mar; 135():111235. PubMed ID: 33561650
[TBL] [Abstract][Full Text] [Related]
15.
Li H; Shi J; Zhao L; Guan J; Liu F; Huo G; Li B
J Agric Food Chem; 2021 Jan; 69(1):183-197. PubMed ID: 33353302
[TBL] [Abstract][Full Text] [Related]
16. Microbiota, a key player in alcoholic liver disease.
Cassard AM; Ciocan D
Clin Mol Hepatol; 2018 Jun; 24(2):100-107. PubMed ID: 29268595
[TBL] [Abstract][Full Text] [Related]
17. Lychee (Litchi chinensis Sonn.) Pulp Phenolic Extract Provides Protection against Alcoholic Liver Injury in Mice by Alleviating Intestinal Microbiota Dysbiosis, Intestinal Barrier Dysfunction, and Liver Inflammation.
Xiao J; Zhang R; Zhou Q; Liu L; Huang F; Deng Y; Ma Y; Wei Z; Tang X; Zhang M
J Agric Food Chem; 2017 Nov; 65(44):9675-9684. PubMed ID: 29041775
[TBL] [Abstract][Full Text] [Related]
18. Gut-liver axis in alcoholic liver disease.
Szabo G
Gastroenterology; 2015 Jan; 148(1):30-6. PubMed ID: 25447847
[TBL] [Abstract][Full Text] [Related]
19. The gut-liver axis in liver disease: Pathophysiological basis for therapy.
Albillos A; de Gottardi A; Rescigno M
J Hepatol; 2020 Mar; 72(3):558-577. PubMed ID: 31622696
[TBL] [Abstract][Full Text] [Related]
20. Intestinal permeability, microbial translocation, changes in duodenal and fecal microbiota, and their associations with alcoholic liver disease progression in humans.
Maccioni L; Gao B; Leclercq S; Pirlot B; Horsmans Y; De Timary P; Leclercq I; Fouts D; Schnabl B; Stärkel P
Gut Microbes; 2020 Nov; 12(1):1782157. PubMed ID: 32588725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
